The U.S. obesity rate declined for the first time in a decade last year, coinciding with the rise of GLP-1 weight-loss ...

Over half of American adults are eligible for semaglutide, but insurance and other barriers make it hard for people to access ...

Britons paying privately for obesity drugs are increasingly choosing Eli Lilly's Mounjaro over Novo Nordisk's Wegovy, online ...

Popular GLP-1 medications like semaglutide in Ozempic and Wegovy help people lose weight, but what should patients know about ...

Ironically, Ozempic and Wegovy, as with many of Novo Nordisk’s other products ... They’re concerned about falling behind the ...

It is crucial for patients using Wegovy to commit to a long-term treatment plan, as stopping the medication can lead to ...

The Biden administration has called for Medicare and Medicaid to expand coverage of weight-loss drugs for people struggling ...

Struggles with obesity are a longstanding issue for millions of Americans and thousands of Iowans, but recent advancements in ...

Elon Musk validated the use of GLP-1 drugs in a post on X on Wednesday. But Robert F. Kennedy Jr. has said he's opposed to Americans using them to fight obesity.

A few years ago, West Virginia, which has the highest obesity rate in the nation, quietly began a small and unusual pilot ...

The European Medicines Agency (EMA) will allow Novo Nordisk to add risk reduction for events related to kidney disease to the ...